- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03966300
Improving the School Vaccination Experience: What CARDs Are You Going to Play?
Playing CARDs to Improve the Vaccination Experience at School: a Cluster Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Vaccination hesitancy is identified by the World Health Organization (WHO) as one of ten threats to global health. The WHO's 3C model of vaccination hesitancy identifies 3 domains of vaccine hesitancy: 1) Confidence (trust in health care providers), 2) Complacency (perceived importance of vaccine-preventable disease) and 3) Convenience (improving clinic processes). The investigators developed a multifaceted knowledge translation intervention that addresses vaccination hesitancy in school-based vaccinations. The intervention is called The CARD(TM) System (C-Comfort, A-Ask, R-Relax, D-Distract). CARD is a framework for delivering vaccinations that is student-centred and promotes coping. CARD integrates evidence-based interventions related to planning and execution of school vaccination clinics to directly tackle all 3 domains of vaccination hesitancy. It tackles Confidence by improving pain/fear management (it teaches students and public health staff how to reduce student symptoms which improves the vaccination experience and improves student trust in health care providers). It tackles Complacency by educating students about what vaccines are, why they are needed, community immunity, as well as the specific diseases they are being protected against. It tackles Convenience by improving school-based clinic processes by integrating student preferences (e.g., privacy, having a support person present).
In this randomized controlled trial, the investigators will evaluate the impact of CARD (vs. usual care) on student important outcomes and process outcomes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Guelph, Ontario, Canada, L9W 1K3
- Wellington Dufferin Guelph Public Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- grade 7 students eligible for vaccination at school
- public health staff working in the school vaccination program
Exclusion Criteria:
- unable to understand and read English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CARD (multi-faceted knowledge translation intervention)
CARD will be integrated into the school vaccination program.
This includes pre-vaccination day preparation (e.g., planning of clinic spaces, student and school staff education about CARD) and vaccination day activities (e.g., clinic set-up, processes for triaging students, implementing pain/fear/fainting mitigation interventions from CARD during vaccination)
|
The intervention consists of education of relevant stakeholders of best practices and integration of best practices into the vaccination delivery program
Other Names:
|
|
No Intervention: Control (standard/usual care)
There are no specific procedures being undertaken to plan or execute clinics.
Usual practices will be instituted (i.e., no education specific to CARD, nor clinic set-up or execution to incorporate interventions for pain, fear or fainting)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Student fear
Time Frame: within 5 minutes after vaccination
|
student self-reported fear during vaccination, rated on a 0-10 scale
|
within 5 minutes after vaccination
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Student pain
Time Frame: within 5 minutes after vaccination
|
student self-reported pain during vaccination, rated on a 0-10 scale
|
within 5 minutes after vaccination
|
|
Student fainting
Time Frame: within 1 hour after vaccination
|
student fainting during vaccination, yes/no, as assessed by immunizer
|
within 1 hour after vaccination
|
|
Uptake of vaccination
Time Frame: by end of school year
|
proportion of students vaccinated (overall and for each vaccine)
|
by end of school year
|
|
Student dizziness
Time Frame: within 5 minutes of vaccination
|
student self-reported dizziness during vaccination, rated on a 0-10 scale
|
within 5 minutes of vaccination
|
|
Student post-immunization stress-related responses
Time Frame: within 1 hour after vaccination
|
student post-immunization stress-related responses, yes/no, as assessed by immunizer using the WHO immunization Stress Responses Criteria
|
within 1 hour after vaccination
|
|
Utilization of coping strategies
Time Frame: within 5 minutes after vaccination
|
use of individual coping strategies during vaccination (distraction, topical anesthetic, privacy, support person, deep breathing, muscle tension), yes/no, as assessed by immunizer using Documentation Checklist
|
within 5 minutes after vaccination
|
|
Implementation success of CARD
Time Frame: within 3 months of vaccination clinics
|
perceptions of implementation success of CARD program delivery as reported by CARD implementers (primary targets) using the CARD Global Impression Checklist, individual questions (5-point likert scale, higher number represents better outcome).
This information will be supplemented with information from focus groups with implementers and study notes
|
within 3 months of vaccination clinics
|
|
Compliance with CARD
Time Frame: within 3 months of vaccination clinics
|
percent compliance with CARD implementation as assessed by implementers using a CARD compliance checklist.
This information will be supplemented with information from focus groups with implementers and study notes
|
within 3 months of vaccination clinics
|
|
Knowledge of effective coping strategies
Time Frame: within 3 months after vaccination clinics
|
knowledge of effective coping strategies, as assessed using a 10-point investigator-developed knowledge test, administered to implementers
|
within 3 months after vaccination clinics
|
|
Perceptions about pain and fear
Time Frame: within 3 months of vaccination clinics
|
perceptions about pain and fear, as assessed using a 5-point likert scale (higher number represents better outcome) for implementers
|
within 3 months of vaccination clinics
|
|
Perceptions about vaccination program
Time Frame: within 3 months of vaccination clinics
|
perceptions about vaccination program, as assessed using the Vaccination Program Global Impresssion Checklist, individual questions (5-point likert scale, higher number represents better outcome) for implementers
|
within 3 months of vaccination clinics
|
|
Willingness to be vaccinated
Time Frame: within 5 minutes after vaccination
|
student self-reported willingness to be vaccinated, as assessed using a 5-point likert scale (higher number represents better outcome)
|
within 5 minutes after vaccination
|
|
Satisfaction with CARD
Time Frame: within 5 minutes after vaccination
|
student self-reported satisfaction with CARD, as assessed using Student Feedback Survey, individual questions (5-point likert scale, higher number indicates better outcome)
|
within 5 minutes after vaccination
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anna Taddio, PhD, University of Toronto
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 37598
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.